论文部分内容阅读
由于外科技术的改进、术后加用放射及化学药物,肾母细胞瘤(威姆斯氏瘤)的控制率已达到89%。然而,仍有25～30%患儿在首次诊断时已有血行转移(肝、肺)。作者报导全肺放射合併放线菌素D治疗13例转移性肾母细胞瘤,2年健在率达54%(二年生存率为62%)。肺转移者采用~(60)钴或4 MeV电子加速器,照射双侧肺部,剂量1,000～3,500拉得(肺部中心剂量,不作校正),放线菌素D每日一次,按每公斤体重15微克计算,5次为一个疗程,以后每隔3个月给一个疗程,直至
Thanks to the improvement of surgical techniques and the addition of radiotherapy and chemical drugs after surgery, the control rate of Wilms’ tumor has reached 89%. However, there are still 25 to 30% of children with hematological metastases (liver, lung) at the time of first diagnosis. The authors reported whole lung radiotherapy with actinomycin D in the treatment of 13 cases of metastatic Wilms tumor, with a 2 year survival rate of 54% (two-year survival rate was 62%). Patients with lung metastases were treated with ~(60)Co or 4 MeV electron accelerators to both sides of the lungs, with doses ranging from 1,000 to 3,500 pulled (central lung dose, without correction), and actinomycin D once daily at a rate of one kilogram body weight. 15 micrograms calculation, 5 times for a course of treatment, after each 3 months to give a course of treatment, until